tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Sarepta Therapeutics: Hold Rating Amid Debt Maturity Extension and Strategic Execution Focus
PremiumRatingsSarepta Therapeutics: Hold Rating Amid Debt Maturity Extension and Strategic Execution Focus
6d ago
Walmart reports mixed Q2, Thoma Bravo to acquire Dayforce: Morning Buzz
Premium
The Fly
Walmart reports mixed Q2, Thoma Bravo to acquire Dayforce: Morning Buzz
7d ago
Sarepta debt refinancing eases liquidity concerns, says Barclays
Premium
The Fly
Sarepta debt refinancing eases liquidity concerns, says Barclays
7d ago
Citi says FDA may take ‘more comprehensive look’ at Sarepta Elevidys adjustment
PremiumThe FlyCiti says FDA may take ‘more comprehensive look’ at Sarepta Elevidys adjustment
8d ago
Sarepta price target raised to $17 from $10 at BofA
Premium
The Fly
Sarepta price target raised to $17 from $10 at BofA
8d ago
Cautious Outlook on Sarepta Therapeutics Amid Uncertain Elevidys Launch and PMO Franchise Risks
Premium
Ratings
Cautious Outlook on Sarepta Therapeutics Amid Uncertain Elevidys Launch and PMO Franchise Risks
8d ago
Sarepta loses credibility by exiting Arrowhead at loss, says H.C. Wainwright
PremiumThe FlySarepta loses credibility by exiting Arrowhead at loss, says H.C. Wainwright
14d ago
Sarepta Therapeutics Announces Strategic Restructuring Plan
Premium
Company Announcements
Sarepta Therapeutics Announces Strategic Restructuring Plan
15d ago
Arrowhead redeems $50M of common stock
Premium
The Fly
Arrowhead redeems $50M of common stock
15d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100